This bid is closed — responses were due May 25, 2026.
It is no longer accepting submissions. We keep closed bids on BidsNexus for reference: agencies often re-issue the same need, and past bids show what they buy and when.
This bid is for the preclinical development of Cap-dependent endonuclease inhibitors (CENis) as broad-spectrum antiviral therapeutics, including activities required to select lead candidates.
Line Items
Item
Qty
Unit
Est. Unit Price
Est. Total
Category
Preclinical development services for Cap-dependent endonuclease inhibitors (CENis)
1
lot
$500,000.00
$500,000.00
Professional Services
Lead CENi candidate selection services
1
lot
—
—
Professional Services
Estimated Bid Value
$500,000.00
Want the full details?
Sign up free to see the agency name and the original bid posting link. Pro adds the 3 documents, contracting-officer contacts and AI response outlines.